Follicular Lymphoma
📧 Sign up to get email alerts when something new happens for Follicular Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS safety_alert · 2025-01-24Clinical Trial Update: A Study to Evaluate Adverse Events of Subcutaneous (SC) Epcoritamab Administered in the Outpatient Setting in Adult Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma and Classic Follicular Lymphoma [Phase 2]
An update on a Phase 2 study evaluating adverse events of subcutaneous epcoritamab in adults with relapsed or refractory diffuse large B-cel…
-
EMA safety_alert · 2016-03-11EMA reviews cancer medicine Zydelig
The EMA reviews the cancer medicine Zydelig (idelalisib) for potential safety concerns and evaluates available data.